Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Clinical Pharmacology
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program
  • Diversity

User Detail

David G Harrison, MD

Division of Clinical Pharmacology

Professor of Medicine

Betty and Jack Bailey Chair in Cardiology

Director, Division of Clinical Pharmacology

David G Harrison
Professional Bio
David G. Harrison, MD, FACC, FAHA, is the Director of the Division of Clinical Pharmacology and a Professor of Medicine within the Department of Medicine at Vanderbilt University Medical Center. His research laboratory has been focused on understanding how inflammation, and in particular, the adaptive immune response contributes to hypertension. Several years ago, they found that T cells are essential for the development of hypertension. His lab has shown that various hypertensive stimuli, including angiotensin II, norepinephrine and DOCA-salt cause activation of T cells and leads to their accumulation in the perivascular fat and kidneys. The data indicates that T cell-derived cytokines such as IL-17 and TNF-a enhance vasoconstriction and sodium retention, leading to the hypertensive phenotype. Central signals derived from the circumventricular organs contribute to T cell activation, and manipulation of signals from this region affect T cell activation and the eventual elevation in blood pressure caused by angiotensin II. Dr. Harrison’s lab is studying mechanisms involved in T cell activation in response to hypertensive stimuli. They have recently shown that gamma-ketoaldehydes, or isoketals adduct to proteins in hypertensive mice and humans, and that these are immunogenic. These modified proteins seem to act as 'auto-antigens' that promote dendritic cell and ultimately T cell activation in hypertension.
Publications
View Publications

Education

MD - Oklahoma State University, 1974

Internship - Duke University, 1975

Residency - Duke University, 1977

Fellowship - CA - University of Iowa, 1982

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Diversity
  • Intranet

Contact Us

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Support Our Work

Give Now

© Copyright 2023 Vanderbilt University Medical Center
Vanderbilt University Medical Center is committed to principles of equal opportunity and affirmative action. EOE/AA/Women/Minority/Vets/Disabled

sfy39587stp18